Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Return on Sales (2016 - 2026)

Biomerica's Return on Sales history spans 17 years, with the latest figure at 1.33% for Q1 2026.

  • Quarterly results put Return on Sales at 1.33% for Q1 2026, down 29.0% from a year ago — trailing twelve months through Feb 2026 was 0.96% (down 13.0% YoY), and the annual figure for FY2025 was 0.94%, up 15.0%.
  • Return on Sales for Q1 2026 was 1.33% at Biomerica, down from 1.09% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2025 to a low of 2.06% in Q2 2025.
  • The 5-year median for Return on Sales is 1.09% (2025), against an average of 1.02%.
  • The sharpest move saw Return on Sales soared 129bps in 2022, then crashed -147bps in 2023.
  • Year by year, Return on Sales stood at 1.1% in 2022, then increased by 12bps to 0.96% in 2023, then surged by 40bps to 0.58% in 2024, then crashed by -88bps to 1.09% in 2025, then dropped by -22bps to 1.33% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods came in at 1.33%, 1.09%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.